欧美……一区二区三区,欧美日韩亚洲另类视频,亚洲国产欧美日韩中字,日本一区二区三区dvd视频在线

南京科佰生物科技有限公司

主營產(chǎn)品: atcc代理,ATCC細胞系,ATCC細胞株,ATCC細胞庫購買

10

聯(lián)系電話

18066071954

您現(xiàn)在的位置: 南京科佰生物科技有限公司>>藥靶細胞株>>kinase激酶細胞株>> CBP73192SLC34A2-ROS1 G2032R/BaF3

公司信息

聯(lián)人:
蔣經(jīng)理
話:
4008750250
機:
18066071954
真:
址:
南京市棲霞區(qū)緯地路9號
編:
210000
化:
www.co-bioer.com
網(wǎng)址:
www.cobioer.com/
鋪:
http://www.hbwxwy.cn/st281842/
給他留言
CBP73192SLC34A2-ROS1 G2032R/BaF3
SLC34A2-ROS1 G2032R/BaF3
參考價 面議
具體成交價以合同協(xié)議為準
  • 型號 CBP73192
  • 品牌 cobioer/科佰生物
  • 廠商性質(zhì) 代理商
  • 所在地 南京市

更新時間:2022-05-05 16:49:34瀏覽次數(shù):606

聯(lián)系我們時請說明是化工儀器網(wǎng)上看到的信息,謝謝!

【簡單介紹】
供貨周期 現(xiàn)貨 規(guī)格 T-25 Flask
貨號 CBP73192 應(yīng)用領(lǐng)域 生物產(chǎn)業(yè)
主要用途 僅限科研使用
SLC34A2-ROS1 [G2032R]/BaF3,母細胞:BaF3,凍存條件:90% FBS+10% DMSO
【詳細說明】
CBP73192
I. Introduction

Cell Line Name:

SLC34A2-ROS1 [G2032R]/BaF3

Host Cell:

Ba/F3

Stability:16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.)

Application:

Anti-proliferation assay and PD assay

Freeze Medium:

90% FBS+10% DMSO

Complete Culture Medium:

RPMI-1640+10%FBS

Mycoplasma Status:

Negative


II.Background

Approximately 2% of lung tumors harbor ROS1 fusions (Bergethon et al. 2012). Like ALK fusions, ROS1 fusions are more commonly found in light smokers (<10 pack years) and/or never-smokers. ROS1 fusions are also associated with younger age and adenocarcinomas (Bergethon et al. 2012).

In preclinical models, ROS1 fusions are associated with sensitivity to tyrosine kinase inhibitors that have 'off-target' activity against ROS1, such as crizotinib (Bergethon et al. 2012; Davies et al. 2012). In addition, two patients—a previously treated metastatic NSCLC patient and a 65-year-old never smoker NSCLC patient—with tumors harboring ROS1 fusions have had partial responses to crizotinib (Bergethon et al. 2012; Davies et al. 2012). In an expansion cohort of a phase I study, 50 patients with ROS1-positive NSCLC demonstrated a 72% response rate and 19.2-month median progression-free survival interval when treated with crizotinib (Ou et al. 2013; Shaw et al. 2014). In a European case study, 32 ROS1-positive NSCLC cases treated with crizotinib were retrospectively reviewed, and an 80% response rate and a 9.1-month median progression-free survival interval was calculated in this cohort (Mazières et al. 2015).

Several different ROS1 rearrangements have been described in NSCLC. These include SLC34A2-ROS1, CD74-ROS1, EZR-ROS1, TPM3-ROS1, and SDC4-ROS1 (Figure 1; Davies et al. 2012; Rikova et al. 2007; Takeuchi et al. 2012). Clinically, the presence of a ROS1 rearrangement is detected by fluorescence in situ hybridization (FISH) with a ROS1 breakapart probe. FISH testing is not able to discern which particular ROS1 fusion is found in a clinical sample.

ROS1 rearrangements are non-overlapping with other oncogenic mutations found in NSCLC (e.g., EGFR mutations, KRAS mutations, ALK fusions, etc.; Bergethon et al. 2012).


III. Representative Data

1. WB of SLC34A2-ROS1 [G2032R]/BaF3expression

CBP73192 WB.png


Figure 1. Protein Expression of ROS1 detected by antibody


2.Sanger Sequencing of SLC34A2-ROS1 Fusion and G2032R mutation

CBP73192 sanger-1.png

Figure 2. SLC34A2-ROS1 Fusion

CBP73192 sanger2.png

Figure 3. ROS1 p.G2032R


3. Anti-proliferation assay

CBP73192 fig.png

Figure 4. Anti-proliferation assay of two reference compounds on the SLC34A2-ROS1 [G2032R]/BaF3 Stable Cell Line.





產(chǎn)品對比 產(chǎn)品對比 二維碼 在線交流

掃一掃訪問手機商鋪

對比框

在線留言
熟女综合乱一区二区三区四区| 久久国产精品户外露出| 欧美中文日韩精品国产字幕| 国产欧美一区二区三区高清| 欧美不卡一区二区三区在线| 甜蜜的妻子在线免费观看| 日韩欧美国产成人高清| 精品少妇一区二区三区在线播放| 亚洲天堂成人资源网站| 久久久国产成人精品二区| 亚洲青青草成人在线视频| 熟女亚洲一区二区三区| 国产亚洲天堂一区二区| 亚洲欧美在线国产色图| 欧美精品一区二区三区 高清| 亚洲熟女激情一区二区| 欧美亚洲另类久久综合| 日韩国产欧美一区二区三区| 亚洲一区二区三区图片小说| 欧美人与黑人午夜性猛交久久久| 一级黄色按摩风骚的少妇| 韩国三级我邻居的妻子| 久久国模国产亚洲av久| 国产熟女露脸自拍不卡| 日韩国产主播av在线| 亚洲欧美自拍偷拍色图| 无套内射骚货在线观看| 欧美亚洲激情网址在线| 日本人妻熟女一区二区| 久久国产精品久久喷水| 国产大陆在线播放av| 亚洲av丝袜一区二区| 操色妞吧在线观看视频| 丰满少妇私密按摩免费观看| 欧美日韩久久久一区二区| 久久国产成人一区二区| av黄色录像在线观看| 人妻丝袜制服一区二区| 国产婷婷色综合成人精品| 人妻久久久中文字幕精品免费| 色综合天天综合网天天|